Abstract
The accurate diagnosis and management of hypertension is based on out-of-office blood pressure (BP) measurements. Home BP monitoring has several advantages over office and ambulatory BP monitoring including convenience and the ability to obtain repeated measurements in the usual environment of the individual over several days, weeks, or months. Evidence on the role of home BP monitoring in special populations including children and adolescents, pregnant women, and patients with renal disease is currently accumulating. In children, as in adults, home BP appears to be a useful alternative to ambulatory monitoring in detecting white-coat and masked hypertension and in following children treated for hypertension. In pregnancy, the potential for home BP monitoring in following women with hypertension and in the early identification of preeclampsia is fundamental. In patients with chronic kidney disease home BP has been shown to be prognostically superior to office BP in predicting end-stage renal disease. Moreover, home BP recordings are superior to peridialysis BP measurements in predicting all-cause mortality. Duplicate, morning and evening home BP measurements for 7 days (minimum of 3 days) are recommended for optimal home BP evaluation. In end-stage renal disease patients on hemodialysis, it is recommended that home BP be measured twice daily, at bedtime and on waking, after the midweek dialysis for 4 days. Automated oscillometric devices that have been successfully validated in adults may not be accurate in children, pregnant women, and in patients with nephropathy, and separate validation is required.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34:1887–920.
Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140:pii: e20171904.
Stergiou GS, Alamara CV, Vazeou A, Stefanidis CJ. Office and out-of-office blood pressure measurement in children and adolescents. Blood Press Monit. 2004;9:293–6.
Stergiou GS, Ntineri A, Kollias A, Stambolliu E, Kapogiannis A, Vazeou A, et al. Home blood pressure monitoring in pediatric hypertension: the US perspective and a plan for action. Hypertens Res. 2018;41:662–8.
Stergiou GS, Ntineri A. Methodology and applicability of home blood pressure monitoring in children and adolescents. In: Flynn J, Ingelfinger J, Redwine K, editors. Pediatric Hypertension. Cham: Springer; 2018. p. 305–21. https://doi.org/10.1007/978-3-319-31107-4_45.
Bald M, Hoyer PF. Measurement of blood pressure at home: survey among pediatric nephrologists. Pediatr Nephrol. 2001;16:1058–62.
Woroniecki RP, Flynn JT. How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists. Pediatr Nephrol. 2005;20:791–7.
Stergiou GS, Alamara CV, Salgami EV, Vaindirlis IN, Dacou-Voutetakis C, Mountokalakis TD. Reproducibility of home and ambulatory blood pressure in children and adolescents. Blood Press Monit. 2005;10:143–7.
Stergiou GS, Nasothimiou EG, Giovas PP, Rarra VC. Long-term reproducibility of home vs. office blood pressure in children and adolescents: the Arsakeion school study. Hypertens Res. 2009;32:311–5.
Stergiou GS, Nasothimiou E, Giovas P, Kapoyiannis A, Vazeou A. Diagnosis of hypertension in children and adolescents based on home versus ambulatory blood pressure monitoring. J Hypertens. 2008;26:1556–62.
Stergiou GS, Giovas PP, Kollias A, Rarra VC, Papagiannis J, Georgakopoulos D, et al. Relationship of home blood pressure with target-organ damage in children and adolescents. Hypertens Res. 2011;34:640–4.
Kollias A, Dafni M, Poulidakis E, Ntineri A, Stergiou GS. Out-of-office blood pressure and target organ damage in children and adolescents: a systematic review and meta-analysis. J Hypertens. 2014;32:2315–31.
Stergiou GS, Boubouchairopoulou N, Kollias A. Accuracy of automated blood pressure measurement in children: evidence, issues, and perspectives. Hypertension. 2017;69:1000–6.
Stergiou GS, Yiannes NG, Rarra VC, Panagiotakos DB. Home blood pressure normalcy in children and adolescents: the Arsakeion School study. J Hypertens. 2007;25:1375–9.
Stergiou GS, Yiannes NG, Rarra VC. Validation of the Omron 705 IT oscillometric device for home blood pressure measurement in children and adolescents: the Arsakion School study. Blood Press Monit. 2006;11:229–34.
Stergiou GS, Karpettas N, Panagiotakos DB, Vazeou A. Comparison of office, ambulatory and home blood pressure in children and adolescents on the basis of normalcy tables. J Hum Hypertens. 2011;25:218–23.
Stergiou GS, Christodoulakis G, Giovas P, Lourida P, Alamara C, Roussias LG. Home blood pressure monitoring in children: how many measurements are needed? Am J Hypertens. 2008;21:633–8.
Nathan HL, Duhig K, Hezelgrave NL, Chappell LC, Shennan AH. Blood pressure measurement in pregnancy. Obstet Gynaecol. 2015;17:91–8.
Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130–7.
Shennan AH, Green M, Chappell LC. Maternal deaths in the UK: pre-eclampsia deaths are avoidable. Lancet. 2017;389:582–4.
Shennan A, Gupta M, Halligan A, Taylor DJ, de Swiet M. Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry. Lancet. 1996;347:139–42.
Nathan HL, Vousden N, Lawley E, de Greeff A, Hezelgrave NL, Sloan N, et al. Development and evaluation of a novel vital signs alert device for use in pregnancy in low-resource settings. BMJ Innov. 2018;4:192–8.
Tucker KL, Bankhead C, Hodgkinson J, Roberts N, Stevens R, Heneghan C, et al. How do home and clinic blood pressure readings compare in pregnancy? Hypertension. 2018;72:686–94.
von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355:87–92.
Bellamy L, Casas JP, Hingorami AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.
Magee L, von Dadelszen P. Preeclampsia and increased cardiovascular risk. BMJ. 2007;335:945–6.
Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613–22.
Ross-McGill H, Hewison J, Hirst J, Dowswell T, Holt A, Brunskill P, et al. Antenatal home blood pressure monitoring: a pilot randomised controlled trial. BJOG. 2000;107:217–21.
Andersen MJ, Khawandi W, Agarwal R. Home blood pressure monitoring in CKD. Am J Kidney Dis. 2005;45:994–1001.
Rave K, Bender R, Heise T, Sawicki PT. Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy. J Hypertens. 1999;17:597–601.
Agarwal R, Andersen MJ. Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69:406–11.
Santos SF, Mendes RB, Santos CA, Dorigo D, Peixoto AJ. Profile of interdialytic blood pressure in hemodialysis patients. Am J Nephrol. 2003;23:96–105.
Agarwal R, Lewis RR. Prediction of hypertension in chronic hemodialysis patients. Kidney Int. 2001;60:1982–9.
Agarwal R, Peixoto AJ, Santos SF, Zoccali C. Pre and post dialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol. 2006;1:389–98.
Alborzi P, Patel N, Agarwal R. Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol. 2007;2:1228–34.
Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension. 2010;55:762–8.
Agarwal R, Light RP. Chronobiology of arterial hypertension in hemodialysis patients: implications for home blood pressure monitoring. Am J Kidney Dis. 2009;54:693–701.
da Silva GV, de Barros S, Abensur H, Ortega KC, Mion D Jr. Cochrane renal group prospective trial register: CRG060800146. Home blood pressure monitoring in blood pressure control among haemodialysis patients: An open randomized clinical trial. Nephrol Dial Transplant. 2009;24:3805–11.
Bishu K, Gricz KM, Chewaka S, Agarwal R. Appropriateness of antihypertensive drug therapy in hemodialysis patients. Clin J Am Soc Nephrol. 2006;1:820–4.
Agarwal R, Sinha AD, Pappas MK, Abraham TN, Tegegne GG. Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial. Nephrol Dial Transplant. 2014;29:672–81.
Agarwal R, Andersen MJ, Light RP. Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients. Am J Nephrol. 2007;28:210–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG, part of Springer Nature
About this chapter
Cite this chapter
Kollias, A., Shennan, A., Agarwal, R., Ntineri, A., Stergiou, G.S. (2020). Home Blood Pressure Monitoring in Children, Pregnancy, and Chronic Kidney Disease. In: Stergiou, G., Parati, G., Mancia, G. (eds) Home Blood Pressure Monitoring. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-030-23065-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-23065-4_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23064-7
Online ISBN: 978-3-030-23065-4
eBook Packages: MedicineMedicine (R0)